CME Outfitters

12/18/2025

Download resources and collect credit - cmeo.me/BC-137-encore

12/18/2025

👋 Participated in our CME Snack “Spotting the Red Flags: Screening and Risk Strat Like a Pro”?
Help spread the impact—share the activity with your colleagues today! 💬👥
📺 Access: https://cmeo.me/SN-283

🔍 Key practice takeaways:
✅ Prioritize risk stratification for MASLD/MASH
✅ Apply ultrasound + FIB-4 to identify fibrosis (even in less obvious risk profiles)
✅ Aim to increase patient assessments over the next 3–6 months

Metabolic dysfunction-associated steatohepatitis (MASH) is a growing clinical challenge due to its increasing prevalence, complex pathophysiology, and strong association with comorbid conditions such as cardiovascular disease and obesity. Evolving diagnostic criteria, risk stratification tools, and....

12/18/2025

🏥 Hospitalized patients with SARS-CoV-2 infection can still deteriorate quickly—especially with comorbidities or advanced respiratory support.

Get up-to-date, guideline-based education on evidence-driven inpatient therapeutics.
📺 Watch the Snack: https://cmeo.me/SN-279

Hospitalized patients with SARS-CoV-2 infection remain at significant risk of clinical deterioration and death, particularly among those with comorbidities or requiring advanced respiratory support. Despite evolving therapeutic options and published clinical guidelines, real-world implementation of....

12/18/2025

Universal screening for HIV, HBV & HCV can drastically improve outcomes—but it’s still underused.

Faculty Dr. Juhi Moon and Dr. Madison The Public Health Pharmacist® PLLC explore how to increase uptake in ERs, student health centers, and women’s health clinics.

Start watching: https://cmeo.me/MMV-152

Early detection and treatment of human immunodeficiency virus (HIV) and hepatitis B and C (HBV, HCV) are paramount to mitigating the damage associated with these diseases, thus allowing patients to live longer, healthier lives; but many...

12/18/2025

💊 Did you miss our latest BriefCase activity?

Preventing the Preventable: Improving Mycophenolate Practices in Patients of Childbearing Potential is now available on demand. Help protect patients through smarter prescribing practices and REMS adherence.

Put what you learned into practice:
✔️ Remind patients of childbearing potential on mycophenolate to avoid pregnancy—every visit
✔️ Explain REMS tools to all eligible patients
✔️ Report any pregnancy exposures to the Mycophenolate Pregnancy Registry

👉 Share the activity with colleagues: https://cmeo.me/BC-140

Mycophenolate-containing medications are potent immunosuppressants used to prevent organ transplant rejection and to treat (off label) some autoimmune disorders. Despite the well-documented fetal risks associated with mycophenolate, as outlined in the U.S. Food and Drug Administration’s...

12/18/2025

🎁 A Holiday Gift for You! 🎁

We’re offering FREE access to the recorded plenary sessions from the 2025 Early Career Preceptorship Program on ILD: Clinical Advances in Fibrosing ILDs—for a limited time!

✨ Earn up to 4.0 CME/CE credits at no cost while exploring topics such as patient-centered ILD care, diagnostic best practices, current treatment approaches, managing comorbidities, shared decision-making, and career development.

🔔 Access the recordings FREE before January 1st 🔔

👉 Participate now https://cmeo.me/ILDrecordings

Designed for pulmonologists, rheumatologists, NPs, PAs, fellows, and residents with an interest in ILD.

Discover new knowledge and improve your medical expertise. Log in to your CME Outfitter account now to learn, grow, and excel in your healthcare career!

12/17/2025

💡 Calling all transplant specialists, OB/GYNs, rheumatologists, and PCPs:
Are you confident in your approach to pregnancy counseling with patients on mycophenolate?

This brief but impactful CME activity walks you through:
✅ Teratogenic risks
✅ Evidence-based contraception discussions
✅ Registry monitoring essentials

⏱️ 60 minutes. CE credit available.
🎯 cmeo.me/WCV-119

Mycophenolate-containing medications are widely used to prevent organ rejection in transplant recipients and to treat (off label) some autoimmune conditions such as lupus; however, use of these immunosuppressive agents during pregnancy is linked to a significantly...

12/17/2025

Download resources and collect credit - cmeo.me/SN-286-encore

12/17/2025

Lennox-Gastaut syndrome doesn’t just impact children—it’s a lifelong condition requiring evolving, multidisciplinary care.

In this expert-led CME, discover:
🔎 Early & late-onset diagnostic strategies
🧠 Lifespan management techniques
💡 How to support patients & caregivers across decades

Watch now: https://cmeo.me/MMV146AANN

Lennox-Gastaut syndrome (LGS) remains a challenging condition to understand, diagnose, and manage. Neuroscience/neurology clinicians, including nurses and nurse practitioners (NPs), encounter significant challenges in the management of patients with LGS, due to the severe symptoms and...

12/17/2025

With IL-23 inhibitors reshaping IBD care, are you up to speed?

📈 Learn how to evaluate, sequence, and communicate these emerging therapies in clinical practice.
🧠 Join this CME live event on Jan 23 at 3 PM EST.
🔗 https://cmeo.me/MMS-162

Despite major advances in inflammatory bowel disease (IBD) management, real-world data show that many patients continue to experience suboptimal outcomes due to misaligned treatment goals, therapeutic inertia, and limited integration of novel therapies, particularly IL-23 inhibitors—into...

12/17/2025

🧠 MOA breakdown.
🗓️ Dosing schedules.
🩺 Real-world strategies.
This free, on-demand CME demystifies GLP-1 RAs for PCPs, PAs, NPs, and pharmacists.
▶️ https://cmeo.me/SN-269

GLP-1 receptor agonists (GLP-1 RAs) have become a cornerstone of type 2 diabetes (T2D) treatment, with strong endorsements from the American Diabetes Association and the American Association of Clinical Endocrinology. Despite these clear guidelines, GLP-1 RAs...

12/17/2025

💡 Did you know? Delayed recognition of noninfectious PI leads to poorer outcomes—especially in pediatric patients.

✅ Early detection
✅ Tailored therapy
✅ Multidisciplinary care

It starts with education.
🔗 https://cmeo.me/SN-287

Patients living with primary immunodeficiency (PI) disorders face prolonged or severe infections that pose significant challenges to daily life. While infectious PI phenotypes have garnered the most visibility, this focus has left noninfectious variants underrecognized and...